Carbon ion radiation therapy DT: 74Gy/20 fractions
Carbon ion radiation therapy DT: 74Gy/20 fractions: patients with unresectable local recurrent rectal cancer will be treated with carbon ion radiation therapy as re-irradiation
Study summary
Prospective phase II clinical study aim to explore the clinical outcome of patients with unresectable locally recurrent rectal cancer (LRRC) treated with re-irradiation by carbon ion radiotherapy (CIRT)
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* 1\) pathologically confirmed rectal adenocarcinoma (including mucinous adenocarcinoma and signet-ring cell carcinoma) and LRRC confirmed by biopsy or clinical diagnosis,
* 2\) received a radical operation for their primary tumor and regional lymph nodes,
* 3\) received chemo-radiation or radiation in pelvic before CIRT,
* 4\) received re-irradiation by CIRT after their pelvic radiotherapy.
Exclusion Criteria:
* 1\) received more than once prior radiotherapy in the same treatment field,
* 2\) time to the last radiotherapy was \<1 year,
* 3\) space between the lesion to organ at risk (OARs) (bladder or digestive tract) was too close (\<5 mm).
Primary outcome measure(s)
local control — Local control at 3 years after CIRT local control rate of the lesion treated by CIRT
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.